Gj. Schuurhuis et al., Large populations of non-clonogenic early apoptotic CD34-positive cells are present in frozen-thawed peripheral blood stem cell transplants, BONE MAR TR, 27(5), 2001, pp. 487-498
Citations number
37
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
Apoptosis is the common cell death pathway which is initiated by a variety
of different stimuli. The recognition of early apoptotic events would marke
dly improve reliability and convenience of apoptosis assays. In the present
study the vital stain Syto(R)16 in combination with the permeability marke
r 7-amino actinomycin D, (7-AAD) has been used to identify an early stage o
f apoptosis, not detected with trypan blue or 7-AAD alone or with conventio
nal apoptosis tests and not consistently and only partly detected by the ea
rly apoptosis marker annexin V. The method was established using solid tumo
ur cell lines treated with TNF, Subsequently we applied it to determine apo
ptotic populations in CD34(+) peripheral blood progenitor cells obtained fr
om growth factor and/or chemotherapy mobilised patients and frozen/thawed a
ccording to standard stem cell transplantation protocols. In a cell line mo
del as well as CD34(+) progenitor cells, different subpopulations with decr
eased SytoR16 fluorescence (Syto(R)16(int) or Syto(R)16(low), compared with
the normal Syto(R)16(high)) appeared which are not, or only partly, apopto
tic using conventional techniques including morphology or 7-AAD staining: e
g percentages of Syto(R)16(int)/7-AAD(-) and Syto(R)16(low)/7-AAD(-) may am
ount to the majority of cells present in a particular CD34(+) sample. Secon
d, upon further incubation these subpopulations become late apoptotic/secon
dary necrotic much faster than the unmodified Syto(R)16(high) population, a
s determined with 7-AAD staining and morphology. Third, these cells have st
rongly or completely reduced clonogenic capacity for committed (CFU-GM) and
early (LTC-IC, determined only for CD34(+) cells) progenitors. This techni
que needs the inclusion of a blocker of P-glycoprotein, which is highly act
ive in CD34(+) progenitor cells. This prevents the interference of the dete
ction of Syto(R)16(low) apoptotic cells by SytoR16(low) cells resulting fro
m P-glycoprotein activity. By comparison with other apoptosis markers we fo
und that early apoptotic subpopulations were detected in the order SytoR16>
annexin V>7-AAD. In conclusion, the combination of Syto(R)16 and 7-AAD dete
cts apoptotic events earlier than conventional apoptosis techniques or anne
xin V, Compared to the presently available viability tests, it allows a muc
h better estimation of the number of viable clonogenic CD34+ cells after fr
eeze/thawing.